Synopsis
A fully automated beamline for the autonomous collection of data from crystals of macromolecules
Status:
open
Disciplines
Applications
- Macromolecular crystallography
Beam size
- Minimum (H x V) : 10.0
x 10.0
µm²
-
Maximum (H x V) : 100.0
x 100.0
µm²
Detectors
Technical details
MASSIF1 is a unique facility for the high throughput, fully automatic characterisation and data collection of crystals of macromolecules. The service is not designed to replace user visits to the synchrotron but rather to do the hard work of screening crystals or collecting data sets through the night, freeing researchers to spend time on more challenging data collection problems and study the underlying biology.
Beam time is booked flexibly and samples then enter a queuing system, users interact with the beamline by describing experimental requirements, that are used by the beamline software to set data collection parameters, in a database, ISPyB, where results are also viewed and downloaded. The service is made possible using the latest automation, a highly intense X-ray beam (5 x 1012 ph/sec in a flexible spot between 100 and 10 µm diameter) and complex workflows that fully evaluate samples, centre the best volumes and collect diffraction data sets optimised for maximum resolution with minimised radiation damage.
- Svensson, O., Monaco, S., Popov, A. N., Nurizzo, D. & Bowler, M. W. (2015). The fully automatic characterization and data collection from crystals of biological macromolecules, Acta Cryst. D71, 1757-1767
- Bowler, M.W., Nurizzo, D., et al. (2015). MASSIF-1: A beamline dedicated to the fully automatic characterisation and data collection from crystals of biological macromolecules, J. Synchrotron Rad. 22, 1540-1547
- Svensson, O., Gilski, M., Nurizzo, D. & Bowler, M. W. (2018) Multi-position data collection and dynamic beam sizing: recent improvements to the automatic data-collection algorithms on MASSIF-1, Acta Cryst. D74, 433-440
- Bowler, M.W., Svensson, O. & Nurizzo, D. (2016): Fully automatic macromolecular crystallography: the impact of MASSIF-1 on the optimum acquisition and quality of data, Cryst. Rev. 22, 233-249
- Nurizzo, D., Bowler M.W., et al. (2016) RoboDiff: combining a sample changer and goniometer for highly automated macromolecular crystallography experiments, Acta Cryst D72, 966-975
- Svensson, O., Gilski, M., Nurizzo, D. & Bowler, M. W. (2019) A comparative anatomy of protein crystals: lessons from the automatic processing of 56,000 samples IUCrJ 6, 822-831
-
Hutin, S., Van Laer, B., Mueller-Dieckmann, C., Leonard, G., Nurizzo, D., Bowler, M. W. (2019). Fully Autonomous Characterization and Data Collection from Crystals of Biological Macromolecules. J. Vis. Exp. 145, e59032, doi:10.3791/59032
JBP1 and JBP3 have conserved structures but different affinity to base-J
de Vries I., Adamopoulos A., Kazokaite-Adomaitiene J., Heidebrecht T., Fish A., Celie P.H.N., Joosten R.P., Perrakis A.,
Journal of Structural Biology 217, 108161-1-108161-8 (2025)
Evolutionary and molecular basis of ADP-ribosylation reversal by zinc-dependent macrodomains
Ariza A., Liu Q., Cowieson N.P., Ahel I., Filippov D.V., Rack J.G.M.,
Journal of Biological Chemistry 300, 107770-1-107770-20 (2024)
Advancements in NMDA receptor-targeted antidepressants: From d-cycloserine discovery to preclinical efficacy of Lu AF90103
Ascic E., Marigo M., David L., Frisch Herrik K., Grupe M., Hougaard C., Mork A., Jones C.R., Badolo L., Frederiksen K., Boonen H.C.M., Jensen H.S., Kilburn J.P.,
Journal of Medicinal Chemistry 67, 20135-20155 (2024)
4-Anilinoquinazoline derivatives as the first potent NOD1-RIPK2 signaling pathway inhibitors at the nanomolar range
Barczyk A., Six P., Rivoal M., Devos C., Dezitter X., Cornu-Choi M.J., Huard K., Pellegrini E., Cusack S., Dubuquoy L., Millet R., Leleu-Chavain N.,
Journal of Medicinal Chemistry 67, 19304-19322 (2024)
Evolution, structure, and drug-metabolizing activity of mammalian prenylcysteine oxidases
Barone M., Pizzorni L., Fraaije M.W., Mascotti M.L., Mattevi A.,
Journal of Biological Chemistry 300, 107810-1-107810-10 (2024)
4'-ethynyl-2'-deoxycytidine (EdC) preferentially targets lymphoma and leukemia subtypes by inducing replicative stress
Calbert M.L., Chandramouly G., Adams C.M., Saez-Ayala M., Kent T., Tyagi M., Ayyadevara V.S.S.A., Wang Y., Krais J.J., Gordon J., Atkins J., Toma M.M., Betzi S., Boghossian A.S., Rees M.G., Ronan M.M., Roth J.A., Goldman A.R., Gorman N., Mitra R., Childers W.E., Graña X., Skorski T., Johnson N., Hurtz C., Morelli X., Eischen C.M., Pomerantz R.T.,
Molecular Cancer Therapeutics 23, 683-699 (2024)
Add this RSS feed to your favorite RSS reader (Thunderbird, Outlook etc...) or install an add-on to your browser, such as RSSPreview for Firefox